Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992

被引:93
作者
Flood, JM
Weinstock, HS
Guroy, ME
Bayne, L
Simon, RP
Bolan, G
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[3] San Francisco Dept Publ Hlth, Div Control & Prevent, San Francisco, CA USA
[4] San Francisco Gen Hosp, San Francisco, CA USA
[5] Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Human Immunodeficien, Atlanta, GA USA
关键词
D O I
10.1086/515245
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the epidemiology and clinical spectrum of neurosyphilis in a population with high rates of coexisting syphilis and human immunodeficiency virus (HIV) infection, a retrospective analysis of cases in all San Francisco hospitals from 1985 to 1992 was conducted, Neurosyphilis was defined by a newly reactive cerebrospinal fluid VDRL; 117 patients with neurosyphilis were identified, The median age was 39 years, 91% were male, 74 (63%) were white, and 75 (64%) were HIV-infected. Thirty-eight (33%) presented with an early symptomatic neurosyphilis syndrome, Six (5%) had late neurosyphilis, Thirty-eight (32%) patients were asymptomatic, and 35 (30%) had findings attributable to coexisting neurologic diseases. Patients demonstrated high serum nontreponemal (VDRL) titers (median, 1:128) at neurosyphilis presentation, In contrast to the findings from the preantibiotic era, neurosyphilis was identified in young patients most often with HIV coinfection, and early symptomatic syndromes were identified more frequently than late neurosyphilis syndromes.
引用
收藏
页码:931 / 940
页数:10
相关论文
共 36 条
[1]  
[Anonymous], 1987, MMWR-MORBID MORTAL W
[2]   NEUROSYPHILIS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SEROPOSITIVE INDIVIDUALS - A PROSPECTIVE-STUDY [J].
BERGER, JR .
ARCHIVES OF NEUROLOGY, 1991, 48 (07) :700-702
[3]   NEUROLOGIC RELAPSE AFTER BENZATHINE PENICILLIN THERAPY FOR SECONDARY SYPHILIS IN A PATIENT WITH HIV-INFECTION [J].
BERRY, CD ;
HOOTON, TM ;
COLLIER, AC ;
LUKEHART, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (25) :1587-1589
[4]  
BROWN S T, 1976, Journal of the American Venereal Disease Association, V3, P136
[5]   NEUROSYPHILIS IN THE ANTIBIOTIC ERA [J].
BURKE, JM ;
SCHABERG, DR .
NEUROLOGY, 1985, 35 (09) :1368-1371
[6]  
*CDC, 1989, MMWR-MORBID MORTAL W, V38, pS8
[7]   CLINICAL-SIGNIFICANCE OF CEREBROSPINAL-FLUID TESTS FOR NEUROSYPHILIS [J].
DAVIS, LE ;
SCHMITT, JW .
ANNALS OF NEUROLOGY, 1989, 25 (01) :50-55
[8]   CSF-FTA TEST AND THE SIGNIFICANCE OF BLOOD CONTAMINATION [J].
DAVIS, LE ;
SPERRY, S .
ANNALS OF NEUROLOGY, 1979, 6 (01) :68-69
[9]   RESPONSE OF LATENT SYPHILIS OR NEUROSYPHILIS TO CEFTRIAXONE THERAPY IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DOWELL, ME ;
ROSS, PG ;
MUSHER, DM ;
CATE, TR ;
BAUGHN, RE .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (05) :481-488
[10]  
Gjestland T., 1955, ACTA DERM-VENEREOL, V35, P11